Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What is the Effect of Mesenchymal Stem Cell Therapy on Seriously Ill Patients With Covid 19 in Intensive Care? (Prospective Double Controlled Study)

NCT04392778 is registered in ClinicalTrials.gov with SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi as lead sponsor.

NCT NCT04392778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04392778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What is the Effect of Mesenchymal Stem Cell Therapy on Seriously Ill Patients With Covid 19 in Intensive Care? (Prospective Double Controlled Study)
Lead sponsor
SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi
Phase
Phase 1/2
Overall status
Completed
Start date
April 1, 2020
Completion date
November 30, 2020
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid19, multiple organ failure, pneumonia